1. Home
  2. BST vs ATRC Comparison

BST vs ATRC Comparison

Compare BST & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BlackRock Science and Technology Trust of Beneficial Interest

BST

BlackRock Science and Technology Trust of Beneficial Interest

HOLD

Current Price

$40.51

Market Cap

1.4B

Sector

Finance

ML Signal

HOLD

Logo AtriCure Inc.

ATRC

AtriCure Inc.

HOLD

Current Price

$39.22

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BST
ATRC
Founded
2014
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.6B
IPO Year
N/A
2005

Fundamental Metrics

Financial Performance
Metric
BST
ATRC
Price
$40.51
$39.22
Analyst Decision
Strong Buy
Analyst Count
0
9
Target Price
N/A
$52.22
AVG Volume (30 Days)
112.7K
462.9K
Earning Date
01-01-0001
02-11-2026
Dividend Yield
10.36%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$518,304,999.00
Revenue This Year
N/A
$16.90
Revenue Next Year
N/A
$12.25
P/E Ratio
N/A
N/A
Revenue Growth
N/A
15.80
52 Week Low
$27.87
$28.29
52 Week High
$44.50
$43.11

Technical Indicators

Market Signals
Indicator
BST
ATRC
Relative Strength Index (RSI) 52.62 50.78
Support Level $39.48 $40.11
Resistance Level $40.25 $41.33
Average True Range (ATR) 0.69 1.10
MACD 0.06 -0.37
Stochastic Oscillator 67.06 16.07

Price Performance

Historical Comparison
BST
ATRC

About BST BlackRock Science and Technology Trust of Beneficial Interest

BlackRock Science and Technology Trust is a closed-end management investment company. Its investment objective is to provide income and total return through a combination of current income, current gains, and long-term capital appreciation. It focuses on investing, under a normal market condition in equity securities of science and technology companies.

About ATRC AtriCure Inc.

AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.

Share on Social Networks: